Vasodilator dysfunction in aged spontaneously hypertensive rats: Changes in NO synthase III and soluble guanylyl cyclase expression, and in superoxide anion production

Cardiovascular Research

Volumn 37, Issue 3, 1998, Pages 772-779

  Bauersachs, Johann ^a,c   Bouloumié, Anne ^a   Mülsch, Alexander ^a   Wiemer, Gabriele ^b   Fleming, Ingrid ^a   Busse, Rudi ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b Hoechst Marion Roussel   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Endothelium; Hypertension; NO synthase; Smooth muscle; Soluble guanylyl cyclase; Spontaneously hypertensive rats; Superoxide anion

Indexed keywords

BRADYKININ RECEPTOR; DICLOFENAC; GUANYLATE CYCLASE; N(G) NITRO DEXTRO ARGININE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANION TRANSPORT; ARTICLE; BLOOD VESSEL REACTIVITY; ENZYME SYNTHESIS; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; VASODILATATION;

ACETYLCHOLINE; ANALYSIS OF VARIANCE; ANIMALS; AORTA, THORACIC; BRADYKININ; ENDOTHELIUM, VASCULAR; GUANYLATE CYCLASE; HYPERTENSION; ISOENZYMES; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE; PERFUSION; RATS; RATS, INBRED SHR; RATS, INBRED WKY; SUPEROXIDE DISMUTASE; SUPEROXIDES; VASODILATION; VASODILATOR AGENTS;

EID: 0032029120     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00250-2     Document Type: Article

References (37)

1. [1] Busse R, Fleming I. Regulation and functional consequences of endothelial nitric oxide formation. Ann Med 1995;27:331-340.
2. [2] Dominiczak AF, Bohr DF. Nitric oxide and its putative role in hypertension. Hypertens 1995;25:1202-1211.
3. [3] Rees DD, Palmer RMJ, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 1989;86:3375-3378.
4. [4] Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995;377:239-242.
5. [5] Vanhoutte PM, Boulanger CM. Endothelium-dependent responses in hypertension. Hypertens Res 1995;18:87-98.
6. [6] Panza JA, Quyyumi AA, Brush JE, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990;323:22-27.
7. [7] Lüscher TF, Vanhoutte PM. Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertens 1986;8:344-348.
8. [8] Lüscher TF, Diederich D, Weber E, Vanhoutte PM, Bühler FR. Endothelium-dependent responses in carotid and renal arteries of normotensive and hypertensive rats. Hypertens 1988;11:573-578.
9. [9] Mantelli L, Amerini S, Ledda F. Roles of nitric oxide and endothelium-derived hyperpolarizing factor in vasorelaxant effect of acetylcholine as influenced by aging and hypertension. J Cardiovasc Pharmacol 1995;25:595-602.
10. [10] Tschudi M, Criscione L, Lüscher TF. Effect of aging and hypertension on endothelial function of rat coronary arteries. J Hypertens 1991;9:164-165.
11. [11] Crabos M, Coste P, Paccalin M, Tariosse L, Daret D, Besse P, Bonoron-Adèle S. Reduced basal NO-mediated dilation and decreased endothelial NO synthase expression in coronary vessels of spontaneously hypertensive rats. J Mol Cell Cardiol 1997;29:55-65.
12. [12] Grunfeld S, Hamilton CA, Mesaros S, McClain SW, Dominiczak AF, Bohr DF, Malinski T. Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. Hypertens 1995;26:854-857.
13. [13] Rajagopalan S, Kurz S, Münzel T, Tarpey M, Freeman BA, Griendling KK, Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. J Clin Invest 1996;97:1916-1923.
14. [14] Nava E, Noll G, Lüscher TF. Increased activity of constitutive nitric oxide synthase in cardiac endothelium in spontaneous hypertension. Circulation 1995;91:2310-2313.
15. [15] Kelm M, Feelisch M, Krebber T, Deussen A, Motz W, Strauer BE. Role of nitric oxide in the regulation of coronary vascular tone in hearts from hypertensive rats: maintenance of nitric oxide-forming capacity and increased basal production of nitric oxide. Hypertens 1995;25:186-193.
16. [16] Bouloumié A, Bauersachs J, Linz W, Schölkens BA, Wiemer G, Fleming I, Busse R. Endothelial dysfunction coincides with an enhanced NO synthase expression and superoxide anion production. Hypertension 1997;30:934-941.
17. [17] Piper HM, Spahr R, Mertens S, Krüzfeld A, Watanabe H. Microvascular endothelial cells from the heart. In: Piper HM, editor. Cell culture techniques in heart and vessel research. Heidelberg:Springer 1990:159-177.
18. [18] Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
19. [19] Bauersachs J, Hecker M, Busse R. Display of the characteristics of endothelium-derived hyperpolarizing factor by a cytochrome P450-derived arachidonic acid metabolite in the coronary microcirculation. Br J Pharmacol 1994;113:1548-1553.
20. [20] Marsden PA, Schappert KT, Chen HS, Flowers M, Sundell CL, Wilcox JN, Lamas S, Michel T. Molecular cloning and characterization of human endothelial nitric oxide synthase. FEBS Lett 1992;307:287-293.
21. [21] Janssens SP, Shimouchi A, Quertermous T, Bloch DB, Bloch KD. Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem 1992;267:14519-14522.
22. [22] Tso JY, Sun XH, Kao TH, Reece KS, Wu R. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evaluation of the gene. Nucleic Acids Res 1985;13:2485-2502.
23. [23] Fleming I, Fisslthaler B, Busse R. Calcium-signalling in endothelial cells involves activation of tyrosine kinases and leads to the activation of mitogen-activated protein kinases. Circ Res 1995;76:522-529.
24. [24] Hecker M, Preiss C, Schini-Kerth VB, Busse R. Antioxidants differentially affect nuclear factor kappaB-mediated nitric oxide synthase expression in vascular smooth muscle cells. FEBS Lett 1996;380:224-228.
25. 2 receptor antagonists inhibit endothelium-dependent contraction. Hypertens 1990;15:699-703.
26. 2 may be the endothelium-derived contracting factor released by acetylcholine in the aorta of the rat. Hypertens 1990;15:475-481.
27. [27] Kelly RA, Balligand J-L, Smith TW. Nitric oxide and cardiac function. Circ Res 1996;79:363-380.
28. [28] Lüscher TF, Rornero JC, Vanhoutte PM. Bioassay of endothelium-derived vasoactive substances in the aorta of normotensive and spontaneously hypertensive rats. J Hypertens 1986;4:S81-S83.
29. [29] Sawada Y, Sakamaki T, Nakamura T, Sato K, Ono Z, Murata K. Release of nitric oxide in response to acetylcholine is unaltered in spontaneously hypertensive rats. J Hypertens 1994;12:745-750.
30. [30] Nakazono K, Watanabe N, Matsuno K, Sasaki J, Sato T, Inoue M. Does superoxide underlie the pathogenesis of hypertension?. Proc Natl Acad Sci USA 1991;88:10045-10048.
31. [31] Ito H, Torii M, Suzuki T. Decreased superoxide dismutase activity and increased superoxide anion production in cardiac hypertrophy of spontaneously hypertensive rats. Clin Exp Hypertens 1995;17:803-816.
32. [32] Sharma RC, Crawford DW, Kramsch DM, Sevanian A, Jiao Q. Immunolocalization of native antioxidant scavenger enzymes in early hypertensive and atherosclerotic arteries: role of oxygen free radicals. Arterioscleros Thrombos 1992;12:403-415.
33. [33] Papapetropoulos A, Abou-Mohamed G, Marczin N, Murad F, Caldwell RW, Catravas JD. Downregulation of nitrovasodilator-induced cyclic GMP accumulation in cells exposed to endotoxin or interleukin-1 b. Br J Pharmacol 1996;118:1359-1366.
34. [34] Papapetropoulos A, Go C, Murad F, Catravas JD. Mechanisms of tolerance to sodium nitroprusside in rat cultured aortic smooth muscle cells. Br J Pharmacol 1996;117:147-155.
35. [35] Mourlon Legrand MC, Benessiano J, Levy BI. Endothelium., mechanical compliance, and cGMP content in the carotid artery from spontaneously hypertensive rats. J Cardiovasc Pharmacol 1993;21:S26-S30.
36. [36] Shirasaki Y, Kolm P, Nickols GA, Lee TJF. Endothelial regulation of cyclic GMP and vascular responses in hypertension. J Pharmacol Exp Ther 1988;245:53-58.
37. [37] Papapetropoulos A, Marczin N, Snead MD, Cheng C, Milici A, Catravas JD. Smooth muscle cell responsiveness to nitrovasodilators in hypertensive and normotensive rats. Hypertens 1994;23:476-484.